Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Report

China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Industry Market Research Report 2023-2029

  • POSTDATE：Sep 10, 2023
  • PAGES：215
  • REPORT CODE：GMM1786091
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Recombinant Human Granulocyte Colony-Stimulating Factor Injection industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Shenzhen Xinpeng

    • CSPC Baike

    • Kyowa Hakko Kirin Co,Ltd

    • Intas Pharmaceuticals

    • Oversease Manufacturer Company

    • Johnson & Johnson

    • Beijing Sihuan

    • Teva Pharmaceutical

    • Qilu Pharma

    By Type:

    • Non-glycosylated

    • Others

    • Glycosylated

    By Application:

    • Hospital use

    • Others

    • Clinic use

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Overview 2018-2029

    • 1.1 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Industry Development Overview

    • 1.2 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Industry Development History

    • 1.3 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Industry Market Size (2018-2029)

    • 1.4 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Analysis by Type from Production Side

      • 1.4.1 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume, Production Value and Growth Rate of Non-glycosylated (2018-2029)

      • 1.4.2 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume, Production Value and Growth Rate of Glycosylated (2018-2029)

    • 1.5 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Analysis by Application from Consumption End

      • 1.5.1 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume, Sales Value and Growth Rate of Hospital use (2018-2029)

      • 1.5.2 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume, Sales Value and Growth Rate of Clinic use (2018-2029)

    • 1.6 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Analysis by Region

      • 1.6.1 North China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate from 2018-2029

    Chapter 2 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Status and Competition Analysis in 2023

      • 2.2.3 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Recombinant Human Granulocyte Colony-Stimulating Factor Injection Industry Development

    Chapter 3 Recombinant Human Granulocyte Colony-Stimulating Factor InjectionIndustry Chain Analysis

    • 3.1 Recombinant Human Granulocyte Colony-Stimulating Factor Injection Industry Chain

    • 3.2 Recombinant Human Granulocyte Colony-Stimulating Factor Injection Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market

    • 3.3 Recombinant Human Granulocyte Colony-Stimulating Factor Injection Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market

    Chapter 4 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Type

    • 4.1 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Total Production Volume and Growth Rate from Production Side

    • 4.5 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume and Growth Rate, by Type

      • 4.5.1 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume and Growth Rate of Non-glycosylated

      • 4.5.2 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume and Growth Rate of Others

      • 4.5.3 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume and Growth Rate of Glycosylated

    Chapter 5 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Total Market Size and Growth Rate from Consumption End

    • 5.5 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate, by Application

      • 5.5.1 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate of Hospital use

      • 5.5.2 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate of Others

      • 5.5.3 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate of Clinic use

    Chapter 6 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Region

    • 6.1 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume and Production Value, by Region

    • 6.2 China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume and Sales Value, by Region

    Chapter 7 North China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Analysis

    • 7.1 North China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Type

    • 7.2 North China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Application

    Chapter 8 Central China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Analysis

    • 8.1 Central China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Type

    • 8.2 Central China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Application

    Chapter 9 South China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Analysis

    • 9.1 South China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Type

    • 9.2 South China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Application

    Chapter 10 East China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Analysis

    • 10.1 East China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Type

    • 10.2 East China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Application

    Chapter 11 Northeast China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Analysis

    • 11.1 Northeast China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Type

    • 11.2 Northeast China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Application

    Chapter 12 Southwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Analysis

    • 12.1 Southwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Type

    • 12.2 Southwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Application

    Chapter 13 Northwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Analysis

    • 13.1 Northwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Type

    • 13.2 Northwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Shenzhen Xinpeng

        • 14.1.1 Shenzhen Xinpeng Company Profile

        • 14.1.2 Shenzhen Xinpeng Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 CSPC Baike

        • 14.2.1 CSPC Baike Company Profile

        • 14.2.2 CSPC Baike Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Kyowa Hakko Kirin Co,Ltd

        • 14.3.1 Kyowa Hakko Kirin Co,Ltd Company Profile

        • 14.3.2 Kyowa Hakko Kirin Co,Ltd Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Intas Pharmaceuticals

        • 14.4.1 Intas Pharmaceuticals Company Profile

        • 14.4.2 Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Oversease Manufacturer Company

        • 14.5.1 Oversease Manufacturer Company Company Profile

        • 14.5.2 Oversease Manufacturer Company Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Johnson & Johnson

        • 14.6.1 Johnson & Johnson Company Profile

        • 14.6.2 Johnson & Johnson Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Beijing Sihuan

        • 14.7.1 Beijing Sihuan Company Profile

        • 14.7.2 Beijing Sihuan Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Teva Pharmaceutical

        • 14.8.1 Teva Pharmaceutical Company Profile

        • 14.8.2 Teva Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Qilu Pharma

        • 14.9.1 Qilu Pharma Company Profile

        • 14.9.2 Qilu Pharma Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Recombinant Human Granulocyte Colony-Stimulating Factor Injection Industry Research Conclusions

    • 15.2 Recombinant Human Granulocyte Colony-Stimulating Factor Injection Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Industry Market Size (2018-2029)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume, Production Value and Growth Rate of Non-glycosylated (2018-2029)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume, Production Value and Growth Rate of Glycosylated (2018-2029)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume, Sales Value and Growth Rate of Hospital use (2018-2029)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume, Sales Value and Growth Rate of Clinic use (2018-2029)

    • Figure North China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate from 2018-2029

    • Figure Central China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate from 2018-2029

    • Figure South China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate from 2018-2029

    • Figure East China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate from 2018-2029

    • Figure Recombinant Human Granulocyte Colony-Stimulating Factor Injection Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Share by Type in 2018

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Share by Type in 2023

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume and Growth Rate of Non-glycosylated (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume and Growth Rate of Glycosylated (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Share by Application in 2018

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Share by Application in 2023

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Total Market Size and Growth Rate from Consumption End

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate of Hospital use (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate of Others (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Market Size and Growth Rate of Clinic use (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume by Region (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Region (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Region (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Value by Region (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Value Share by Region (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Value Share by Region (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume by Region (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Region (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Region (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Value by Region (2018-2023)

    • Table China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Value Share by Region (2018-2023)

    • Figure China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Value Share by Region (2018-2023)

    • Table North China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume by Type (2018-2023)

    • Table North China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Type (2018-2023)

    • Figure North China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Type (2018-2023)

    • Table North China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume by Application (2018-2023)

    • Table North China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Application (2018-2023)

    • Figure North China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Application (2018-2023)

    • Table Central China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume by Type (2018-2023)

    • Table Central China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Type (2018-2023)

    • Figure Central China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Type (2018-2023)

    • Table Central China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume by Application (2018-2023)

    • Table Central China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Application (2018-2023)

    • Figure Central China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Application (2018-2023)

    • Table South China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume by Type (2018-2023)

    • Table South China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Type (2018-2023)

    • Figure South China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Type (2018-2023)

    • Table South China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume by Application (2018-2023)

    • Table South China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Application (2018-2023)

    • Figure South China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Application (2018-2023)

    • Table East China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume by Type (2018-2023)

    • Table East China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Type (2018-2023)

    • Figure East China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Type (2018-2023)

    • Table East China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume by Application (2018-2023)

    • Table East China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Application (2018-2023)

    • Figure East China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Application (2018-2023)

    • Table Northeast China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume by Type (2018-2023)

    • Table Northeast China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Type (2018-2023)

    • Figure Northeast China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Type (2018-2023)

    • Table Northeast China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume by Application (2018-2023)

    • Table Northeast China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Application (2018-2023)

    • Table Southwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume by Type (2018-2023)

    • Table Southwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Type (2018-2023)

    • Figure Southwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Type (2018-2023)

    • Table Southwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume by Application (2018-2023)

    • Table Southwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Application (2018-2023)

    • Table Northwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume by Type (2018-2023)

    • Table Northwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Type (2018-2023)

    • Figure Northwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Production Volume Share by Type (2018-2023)

    • Table Northwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume by Application (2018-2023)

    • Table Northwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Recombinant Human Granulocyte Colony-Stimulating Factor Injection Sales Volume Share by Application (2018-2023)

    • Table Shenzhen Xinpeng Company Profile

    • Table Shenzhen Xinpeng Recombinant Human Granulocyte Colony-Stimulating Factor Injection Revenue, Price and Gross (2018-2023)

    • Table CSPC Baike Company Profile

    • Table CSPC Baike Recombinant Human Granulocyte Colony-Stimulating Factor Injection Revenue, Price and Gross (2018-2023)

    • Table Kyowa Hakko Kirin Co,Ltd Company Profile

    • Table Kyowa Hakko Kirin Co,Ltd Recombinant Human Granulocyte Colony-Stimulating Factor Injection Revenue, Price and Gross (2018-2023)

    • Table Intas Pharmaceuticals Company Profile

    • Table Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection Revenue, Price and Gross (2018-2023)

    • Table Oversease Manufacturer Company Company Profile

    • Table Oversease Manufacturer Company Recombinant Human Granulocyte Colony-Stimulating Factor Injection Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Recombinant Human Granulocyte Colony-Stimulating Factor Injection Revenue, Price and Gross (2018-2023)

    • Table Beijing Sihuan Company Profile

    • Table Beijing Sihuan Recombinant Human Granulocyte Colony-Stimulating Factor Injection Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Company Profile

    • Table Teva Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection Revenue, Price and Gross (2018-2023)

    • Table Qilu Pharma Company Profile

    • Table Qilu Pharma Recombinant Human Granulocyte Colony-Stimulating Factor Injection Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US